2017-05730. Importer of Controlled Substances Registration  

  • Start Preamble

    ACTION:

    Notice of registration.

    SUMMARY:

    Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The companies listed below applied to be registered as importers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.Start Printed Page 14914

    CompanyFR docketPublished
    Fisher Clinical Services, Inc81 FR 61248September 6, 2016.
    Sigma-Aldrich International:
    GMBH-Sigma Aldrich Company LLC81 FR 63223September 14, 2016.
    Fisher Clinical Services, Inc81 FR 68455October 4, 2016.
    Anderson Brecon, Inc81 FR 71766October 18, 2016.
    Johnson Matthey Inc81 FR 71766October 18, 2016.
    Wildlife Laboratories, Inc81 FR 95644December 28, 2016.
    Noramco, Inc81 FR 95640December 28, 2016.
    Mylan Technologies, Inc82 FR 7859January 23, 2017.

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons.

    Start Signature

    Dated: March 17, 2017.

    Louis J. Milione,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2017-05730 Filed 3-22-17; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
03/23/2017
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of registration.
Document Number:
2017-05730
Pages:
14913-14914 (2 pages)
Docket Numbers:
Docket No. DEA-392
PDF File:
2017-05730.Pdf